AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,045 | 45,737 | -52,092 | -26,842 | -7,205 |
| Depreciation Amortization | 2,098 | 1,282 | 983 | 590 | 282 |
| Accounts payable and accrued liabilities | 2,322 | -1,857 | 883 | -2,900 | 2,632 |
| Other Working Capital | -4,878 | 5,687 | 1,853 | -2,022 | 3,349 |
| Other Operating Activity | 3,022 | 4,730 | 3,308 | 8,720 | -4,790 |
| Operating Cash Flow | $-63,481 | $55,579 | $-45,065 | $-22,454 | $-5,732 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 31,998 | -65,423 | -30,672 | N/A | N/A |
| PPE Investments | -1,751 | -1,897 | -1,900 | -1,831 | -913 |
| Other Investing Activity | -31 | 0 | -182 | -41 | 0 |
| Investing Cash Flow | $30,216 | $-67,320 | $-32,754 | $-1,872 | $-913 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 50,805 | 202 | 203 | N/A |
| Common Stock Issued | 259 | 69 | 114,032 | 72 | 70,755 |
| Common Stock Repurchased | -107 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,009 | -936 | -2,407 | 0 | 9,240 |
| Financing Cash Flow | $-857 | $49,939 | $111,828 | $275 | $79,996 |
| Exchange Rate Effect | -750 | -831 | -1,205 | -4,236 | 3,496 |
| Beginning Cash Position | 206,480 | 157,479 | 127,163 | 154,691 | 77,693 |
| End Cash Position | 171,609 | 194,845 | 159,967 | 126,404 | 154,539 |
| Net Cash Flow | $-34,871 | $37,366 | $32,804 | $-28,287 | $76,846 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,481 | 55,579 | -45,065 | -22,454 | -5,732 |
| Capital Expenditure | -1,820 | -1,897 | -1,900 | -1,831 | -913 |
| Free Cash Flow | -65,300 | 53,682 | -46,965 | -24,286 | -6,645 |